Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ViaLogy selected by Cisco

1 Apr 2008 13:00

ViaLogy PLC01 April 2008 ViaLogy Technology Integrated into New Cisco Open Platform for Safety and Security London, 1 April 2008: ViaLogy PLC (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms, announces its technology is beingintegrated into the Cisco Open Platform for Safety and Security (COPSS), the newCisco technology platform launched today at the annual FOSE 2008 industry tradeshow. The Cisco Open Platform for Safety and Security is a secure, intelligent,converged solution intended for multiple surveillance and alert applications tosupport the growing needs of defence, civilian, public safety, state and localgovernment agencies. It is to be offered by Cisco to public sector organizationson a worldwide basis. As a core member of the solution team, ViaLogy will provide the sensorintegration engine for the platform. ViaLogy's SPMTM (Sensor Policy Manager)software enables disparate sensors in very large enterprise networks to processand report only key events of interest to security personnel. The ViaLogytechnology is sensor agnostic and considerably enhances the performance andstrength of all integrated legacy and IP sensors, thus avoiding false alarms,missed events and optimizing use of limited bandwidth. ViaLogy's SPMTM is anintegral part of the Cisco Open Platform for Safety and Security demonstration -and available for viewing - at Cisco's Center of Excellence in Herndon,Virginia. "We are pleased to be working with Vialogy as part of our go-to-market team forthe Cisco Open Platform for Safety and Security," said Bruce Klein, Cisco'sfederal vice president. "Our strategy is to pull together an 'ecosystem' of theleading companies with expertise in protecting citizens, employees and criticalassets to provide the most comprehensive solution for facilitating collaborationfor government agencies. Vialogy delivers a critical piece of our overalltechnology platform." "Cisco has developed the Cisco Open Platform for Safety and Security to answer aworldwide requirement from customers for improved and co-ordinated integratedsafety and security systems," said Robert W. Dean. President and CEO of ViaLogy,"We are proud to be chosen as an approved supplier to the platform." "SPMTM is a comprehensive and flexible product that can be customised to suitindividual customer needs because we recognise that there are a variety ofsituations to be dealt with. Some customers will want a complete system forsecuring or monitoring a new building or area, others will want the overallintegration of existing and new security arrangements. "The Cisco Open Platform for Safety and Security will give common operationalpicture vigilance of all aspects of security, faster situation assessment,automated decision making and improved response time." ViaLogy has been closely involved in the development of an Improved DecisionSupport System for disparate sensors. As the Department of Defense drivesconvergence of physical security, consequence management and Chemical,Biological, Radiological/Nuclear, and Explosive (CBRNE) incidents to ensuresafety of military bases, scaleable network-centric technologies and IT productsare becoming increasingly important. ViaLogy has demonstrated its successes overthe past year during multiple Department of Defense demonstrations thatcontinually monitored and reported on CBRNE sensors in realistic scenarios.ViaLogy's SPMTM technology flawlessly linked all critical sensors to enableautomatic time alerts to the right person. This sensor integration andinteroperability capability will be a critical factor in next generationnetworked emergency alert systems. To find out more about the Cisco Open Platform for Safety and Security andViaLogy's participation please visit www.vialogy.com. ends Further information from: ViaLogy Robert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0)1235 834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0)20 7107 8000 PR Consultants - Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defence and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.